Summary
In the present study, we report the molecular characterization of a hereditary compound heterozygous protein C (PC) deficiency observed in a male infant with neonatal purpura fulminans, and its prenatal diagnosis done by direct detection of the mutation sites in the PC gene. DNA-sequence analysis of the patient’s and his mother’s PC gene disclosed the presence of a deletion of one of the four consecutive G nucleotides encoding Trp380(TGG)-G1y381(GGT) in exon IX, resulting in a frameshift mutation, and an abnormal sequence of the 81 amino acid residues following Val381; this mutation was the same as previously reported as PC-Nagoya. The patient’s and his father’s PC gene had a missense mutation (G to A) in exon III with a substitution of Lys for G1u26; this mutation was named PC-Mie. This mutation may be responsible for the reduced immunological PC levels detected in the patient and the father, as measured by a monoclonal antibody that recognizes the Gla-domain of PC in a Ca2+-dependent manner (3.8% and 57%, respectively). Abnormal PC/activated PC (APC) purified from the father’s plasma showed a decreased binding ability to phospholipids, thrombomodulin, and to endothelial cell PC receptor, suggesting that Gla26-dependent conformation is required for these bindings. The proband died at 3 years old. Thereafter, the parents insisted on having a healthy baby. The second pregnancy resulted in spontaneous abortion. During the third and fourth pregnancies, prenatal screening of PC abnormalities was performed. We detected the above-mentioned mutations using two methods; one was based on the development of new restriction enzyme sites using mutagenic primer and the other was the single nucleotide primer extension. In the third pregnancy, the fetus presented both paternal and maternal mutations and thus the pregnancy was terminated by artificial abortion. In the fourth pregnancy, the fetus was free from both mutations, the pregnancy continued, and the woman underwent a cesarean section. The plasma level of Gla-PC antigen in the cord of the female baby was within the normal range. Postnatal analysis of her PC gene disclosed identical results to those done in the prenatal period.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Similar content being viewed by others
References
Stenflo J (1976) A new vitamin K-dependent protein. Purification from bovine plasma and preliminary characterization. J Biol Chem 251: 355–363
Kisiel W (1979) Human plasma protein C: isolation, characterization, and mechanism of activation by alpha-thrombin. J Clin Invest 64: 761–769
Esmon NL, Owen WG, Esmon CT (1982) Isolation of a membrane-bound cofactor for thrombin-catalyzed activation of protein C. J Biol Chem 257: 859–864
Esmon CT (1987) The regulation of natural anticoagulant pathways. Science 235: 1348–1352
Esmon CT (1989) The roles of protein C and thrombomodulin in the regulation of blood coagulation. J Biol Chem 264: 4743–4746
de Foun N, Haverkate F, Bertina RM, Koopman J, van Wijngddrden A, van Hinsbergh V (1986) The cofactor role of protein S in the acceleration of whole blood clot lysis by activated protein C in vitro. Blood 67: 1189–1192
Suzuki K, Stenflo J, Dahlback B, Teodorsson B (1983) Inactivation of human coagulation factor V by activated protein C. J Biol Chem 258: 1914–1920
van Hinsbergh V, Bertina RM, van Wijngddrden A, van Tilburg N, Emeis JJ, Haverkate F (1985) Activated protein C decreases plasminogen activator-inhibitor activity in endothelial cellconditioned medium. Blood 65: 444–451
Bajzar L, Nesheim M, Morser J, Tracy PB (1998) Both cellular and soluble forms of thrombomodulin inhibit fibrinolysis by potentiating the activation of thrombinactivable fibrinolysis inhibitor. J Biol Chem 273: 2792–2798
Plutzky J, Hoskins JA, Long GL, Crabtree GR (1986) Evolution and organization of the human protein C gene. Proc Natl Acad Sci USA 83: 546–550
Broekmans AW, Veltkamp JJ, Bertina RM (1983) Congenital protein C deficiency and venous thromboembolism. A study of three Dutch families. N Engl J Med 309: 340–344
Marlar RA, Mastovich S (1990) Hereditary protein C deficiency: a review of the genetics, clinical presentation, diagnosis and treatment. Blood Coagul Fibrinolysis 1: 319–330
Suzuki K, Matsuda Y, Kusumoto H, Nishioka J, Terada M, Yamashita T, Hashimoto S (1985) Monoclonal antibodies to human protein C: effects on the biological activity of activated protein C and the thrombin-catalyzed activation of protein Cl. J Biochem (Tokyo) 97: 127–138
Suzuki K, Hayashi T, Koyama M, Yoshimura T, Shimamoto M, Kimura N, Kita M (1989) Rapid homogeneous enzyme immunoassay of plasma protein C. Clin Chim Acta 184: 227–233
Wakabayashi K, Sakata Y, Aoki N (1986) Conformation-specific monoclonal antibodies to the calcium-induced structure of protein C. J Biol Chem 261:11 097–11 105
Martinoli JL, Stocker K (1986) Fast functional protein C assay using Protac, a novel protein C activator. Thromb Res 43: 253–264
Ido M, Ohiwa M, Hayashi T, Nishioka J, Hatada T, Watanabe Y, Wada H, Shirakawa S, Suzuki K (1993) A compound heterozygous protein C deficiency with a single nucleotide G deletion encoding Gly-381 and an amino acid substitution of Lys for Gla-26. Thromb Haemost 70: 636–641
Nishioka J, Ido M, Hayashi T, Suzuki K (1996) The G1a26 residue of protein C is required for the binding of protein C to thrombomodulin and endothelial cell protein C receptor, but not to protein S and factor Va. Thromb Haemost 75: 275–282
Suzuki K, Hayashi T, Nishioka J, Kosaka Y, Zushi M, Honda G, Yamamoto S (1989) A domain composed of epidermal growth factor-like structures of human thrombomodulin is essential for thrombin binding and for protein C activation. J Biol Chem 264: 4872–4876
Suzuki K, Nishioka J, Hashimoto S (1983) Protein C inhibitor. Purification from human plasma and characterization. J Biol Chem 258: 163–168
Fukudome K, Esmon CT (1994) Identification, cloning, and regulation of a novel endothelial cell protein C/activated protein C receptor. J Biol Chem 269: 2648626491
Saiki RK, Gelfand DH, Stoffel S, Scharf SJ, Higuchi R, Horn GT, Mullis KB, Erlich HA (1988) Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase. Science 239: 487–491
Sanger F, Nicklen S, Coulson AR (1977) DNA sequencing with chain-terminating inhibitors. Proc Natl Acad Sci USA 74: 5463–5467
Kuppuswamy MN, Hoffmann JW, Kasper CK, Spitzer SG, Groce SL, Bajaj SP (1991) Single nucleotide primer extension to detect genetic diseases: experimental application to hemophilia B (factor IX) and cystic fibrosis genes. Proc Natl Acad Sci USA 88: 1143–1147
Yamamoto K, Tanimoto M, Emi N, Matsushita T, Takamatsu J, Saito H (1992) Impaired secretion of the elongated mutant of protein C (protein C-Nagoya). Molecular and cellular basis for hereditary protein C deficiency. J Clin Invest 90: 2439–2446
Tokunaga F, Wakabayashi S, Sato H, Arakawa M, Tawaraya H, Koide T (1992) Identification of one base deletion in exon IX of the protein C gene that causes a type I deficiency. Thromb Res 68: 417–423
Bovill EG, Tomczak JA, Grant B, Bhushan F, Pillemer E, Rainville IR, Long GL (1992) Protein CVermont: symptomatic type II protein C deficiency associated with two GLA domain mutations. Blood 79: 1456–1465
Mimuro J, Muramatsu S, Kaneko M, Yoshitake S, Iijima K, Nakamura K, Sakata Y, Matsuda M (1993) An abnormal protein C (protein C Yonago) with an amino acid substitution of Gly for Arg-15 caused by a single base mutation of C to G in codon 57 (CGG - GGG). Deteriorated calcium-dependent conformation of the gammacarboxyglutamic acid domain relevant to a thrombotic tendency. Int J Hematol 57: 9–14
Zhang L, Jhingan A, Castellino FJ (1992) Role of individual gamma-carboxyglutamic acid residues of activated human protein C in defining its in vitro anticoagulant activity. Blood 80: 942–952
Ido M, Hayashi T, Nishioka J, Itoh M, Minoura H, Toyoda N, Hirayama M, Kawasaki H, Sakurai M, Suzuki K (1996) Prenatal diagnosis of compound heterozygous deficiency of protein C by direct detection of the mutation sites. Thromb Haemost 76: 277–278
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1999 Springer Japan
About this paper
Cite this paper
Ido, M., Hayashi, T., Nishioka, J., Suzuki, K. (1999). Hereditary Thrombophilia Caused by Abnormality of the Anticoagulant Protein C Pathway: Prenatal Diagnosis of Compound Heterozygous Protein C Deficiency by Direct Detection of the Mutation Sites. In: Nakano, T., Goldhaber, S.Z. (eds) Pulmonary Embolism. Springer, Tokyo. https://doi.org/10.1007/978-4-431-66893-0_2
Download citation
DOI: https://doi.org/10.1007/978-4-431-66893-0_2
Publisher Name: Springer, Tokyo
Print ISBN: 978-4-431-66895-4
Online ISBN: 978-4-431-66893-0
eBook Packages: Springer Book Archive